Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali
Authors:
- Hamma MaigaHamma Maiga
- Abdoulaye A DjimdeADAbdoulaye A Djimde
- Abdoul H BeavoguiABAbdoul H Beavogui
- Ousmane ToureOTOusmane Toure
- Mamadou TeketeMTMamadou Tekete
- Cheick Papa O SangareCSCheick Papa O Sangare
- Antoine DaraADAntoine Dara
- Zoumana I TraoreZTZoumana I Traore
- Oumar B TraoreOTOumar B Traore
- Souleymane DamaSDSouleymane Dama
- Christelle N’dongCNChristelle N’dong
- Hamidou NiangalyHNHamidou Niangaly
Open Access
- 7 February 2015
- journal article
- clinical trial
- Published by Springer Nature in Malaria Journal
- Vol. 14 (1) , 64
Abstract
Plasmodium falciparum resistance to artemisinin has been reported in South-East Asia. Long half-life drugs are increasingly being used for malaria prevention. The potential spread of parasite resistance to these regimens is real and makes regular efficacy surveillance a priority. From August to December 2004 and July to December 2005, a randomized open label trial of sulphadoxine-pyrimethamine (SP) + artesunate (AS) versus SP + amodiaquine (AQ), and SP alone, was conducted in two villages of Mali. PCR was used to distinguish new infections from recrudescent P. falciparum infections. Patients were followed for 28 days to assess treatment efficacy. Overall 912 children aged between six to 59 months, with uncomplicated P. falciparum malaria were recruited. Baseline characteristics were similar in the three treatment arms. Crude ACPRs were 94.9%; 98.6% and 93.5% for SP + AS; SP + AQ and SP alone arms respectively (SP + AS versus SP + AQ, p = 0.01; SP + AS versus SP, p = 0.5; SP + AQ versus SP, p = 0.001). After PCR adjustment, cACPRs were 99%; 100% and 97.2% for SP + AS; SP + AQ and SP alone arms, respectively (SP + AS versus SP + AQ, p = 0.25; SP + AS versus SP, p = 0.12; SP + AQ versus SP, p = 0.007). Sulphadoxine-pyrimethamine + amodiaquine therapy was as efficacious as sulphadoxine-pyrimethamine + artesunate, but more efficacious than sulphadoxine-pyrimethamine alone in the treatment of uncomplicated P. falciparum malaria in Mali.Keywords
This publication has 28 references indexed in Scilit:
- Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trialMalaria Journal, 2014
- Malaria Morbidity in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria in Mali: A Randomized Control TrialPLOS ONE, 2011
- Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled TrialPLOS Medicine, 2011
- A molecular map of chloroquine resistance in MaliFEMS Immunology & Medical Microbiology, 2010
- Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapyMalaria Journal, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in MaliMalaria Journal, 2009
- Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, MaliMalaria Journal, 2009
- Spatial distribution of the chromosomal forms of anopheles gambiae in MaliMalaria Journal, 2008
- Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaMalaria Journal, 2007